Israel Neurological Biomarkers Market (2025-2031) | Competitive Landscape, Segmentation, Outlook, Industry, Trends, Analysis, Share, Forecast, Companies, Size & Revenue, Value, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Neurological Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 Israel Neurological Biomarkers Market - Industry Life Cycle

3.4 Israel Neurological Biomarkers Market - Porter's Five Forces

3.5 Israel Neurological Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Neurological Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Israel Neurological Biomarkers Market Revenues & Volume Share, By End Use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in Israel

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Technological advancements in biomarker research and development

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for biomarker validation and approval

4.3.2 High costs associated with biomarker discovery and development

4.3.3 Limited adoption of neurological biomarkers in clinical practice

6.1 Israel Neurological Biomarkers Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Neurological Biomarkers Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Israel Neurological Biomarkers Market Revenues & Volume, By Genomic Biomarkers, 2021- 2031F

6.1.4 Israel Neurological Biomarkers Market Revenues & Volume, By Proteomic Biomarkers, 2021- 2031F

6.1.5 Israel Neurological Biomarkers Market Revenues & Volume, By Metabolomic Biomarkers, 2021- 2031F

6.1.6 Israel Neurological Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F

6.1.7 Israel Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Neurological Biomarkers Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Neurological Biomarkers Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.2.3 Israel Neurological Biomarkers Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.2.4 Israel Neurological Biomarkers Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.2.5 Israel Neurological Biomarkers Market Revenues & Volume, By Autism Spectrum Disorders, 2021- 2031F

6.2.6 Israel Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Neurological Biomarkers Market, By End Use

6.3.1 Overview and Analysis

6.3.2 Israel Neurological Biomarkers Market Revenues & Volume, By Hospital Laboratories, 2021- 2031F

6.3.3 Israel Neurological Biomarkers Market Revenues & Volume, By Clinical Diagnostic Centers, 2021- 2031F

6.3.4 Israel Neurological Biomarkers Market Revenues & Volume, By Research Organizations, 2021- 2031F

6.3.5 Israel Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

7.1 Israel Neurological Biomarkers Market Export to Major Countries

7.2 Israel Neurological Biomarkers Market Imports from Major Countries

8.1 Number of research collaborations between academia and industry for neurological biomarker development

8.2 Percentage of healthcare professionals trained in the use and interpretation of neurological biomarkers

8.3 Growth in the number of publications and patents related to neurological biomarkers in Israel

9.1 Israel Neurological Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Neurological Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Israel Neurological Biomarkers Market Opportunity Assessment, By End Use, 2021 & 2031F

10.1 Israel Neurological Biomarkers Market Revenue Share, By Companies, 2024

10.2 Israel Neurological Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters